EVOLUS, INC. Cost of Revenue
EVOLUS, INC. (EOLS) reported Cost of Revenue of $26.90 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-05
- EVOLUS, INC. cost of goods and services sold for the quarter ending 2026-06-30 was $26.90M, a 11.79% increase year-over-year.
- EVOLUS, INC. cost of goods and services sold for the quarter ending 2026-03-31 was $24.24M, a 10.85% increase year-over-year.
- EVOLUS, INC. cost of goods and services sold for the quarter ending 2025-12-31 was $31.01M, a 17.85% increase year-over-year.
- EVOLUS, INC. cost of goods and services sold for the quarter ending 2025-09-30 was $23.13M, a 21.81% increase year-over-year.
- EVOLUS, INC. cost of goods and services sold for fiscal 2025 was $100.07M, a 19.17% increase from fiscal 2024.
- EVOLUS, INC. cost of goods and services sold for fiscal 2024 was $83.97M, a 30.16% increase from fiscal 2023.
- EVOLUS, INC. cost of goods and services sold for fiscal 2023 was $64.51M, a 9.64% increase from fiscal 2022.
- EVOLUS, INC. cost of goods and services sold for fiscal 2022 was $58.84M, a 35.16% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 3 month as first filed | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 6 month as first filed | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 9 month as first filed | Cost of Goods and Services Sold 12 month | Cost of Goods and Services Sold 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $26.90M 10-Q · filed 2026-08-05 | $51.14M 10-Q · filed 2026-08-05 | $82.15M derived: sum of 3 quarters · filed 2026-08-05 | $105.28M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $24.24M 10-Q · filed 2026-05-04 | $55.25M derived: sum of 2 quarters · filed 2026-05-04 | $78.38M derived: sum of 3 quarters · filed 2026-05-04 | $102.44M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $31.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $54.13M derived: sum of 2 quarters · filed 2026-03-03 | $78.20M derived: sum of 3 quarters · filed 2026-08-05 | $100.07M 10-K · filed 2026-03-03 | ||||
| 2025-09-30 | $23.13M 10-Q · filed 2025-11-05 | $47.19M derived: sum of 2 quarters · filed 2026-08-05 | $69.06M 10-Q · filed 2025-11-05 | $95.37M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $24.07M 10-Q · filed 2026-08-05 | $45.93M 10-Q · filed 2026-08-05 | $72.25M derived: sum of 3 quarters · filed 2026-08-05 | $91.23M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $21.87M 10-Q · filed 2026-05-04 | $48.18M derived: sum of 2 quarters · filed 2026-05-04 | $67.17M derived: sum of 3 quarters · filed 2026-05-04 | $87.01M derived: sum of 4 quarters · filed 2026-05-04 | ||||
| 2024-12-31 | $26.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $45.30M derived: sum of 2 quarters · filed 2026-03-03 | $65.14M derived: sum of 3 quarters · filed 2026-03-03 | $83.97M 10-K · filed 2026-03-03 | ||||
| 2024-09-30 | $18.99M 10-Q · filed 2025-11-05 | $18.22M 10-Q · filed 2024-11-06 | $38.83M derived: sum of 2 quarters · filed 2025-11-05 | $57.66M 10-Q · filed 2025-11-05 | $55.37M 10-Q · filed 2024-11-06 | $79.88M derived: sum of 4 quarters · filed 2026-03-03 | ||
| 2024-06-30 | $19.84M 10-Q · filed 2025-08-05 | $19.08M 10-Q · filed 2024-07-31 | $38.67M 10-Q · filed 2025-08-05 | $37.14M 10-Q · filed 2024-07-31 | $60.90M derived: sum of 3 quarters · filed 2026-03-03 | $76.33M derived: sum of 4 quarters · filed 2026-03-03 | ||
| 2024-03-31 | $18.83M 10-Q · filed 2025-05-07 | $18.07M 10-Q · filed 2024-05-07 | $41.05M derived: sum of 2 quarters · filed 2026-03-03 | $56.49M derived: sum of 3 quarters · filed 2026-03-03 | $71.20M derived: sum of 4 quarters · filed 2026-03-03 | |||
| 2023-12-31 | $22.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $37.66M derived: sum of 2 quarters · filed 2026-03-03 | $52.37M derived: sum of 3 quarters · filed 2026-03-03 | $64.51M 10-K · filed 2026-03-03 | $61.56M 10-K · filed 2024-03-07 | |||
| 2023-09-30 | $15.43M 10-Q · filed 2024-11-06 | $30.14M derived: sum of 2 quarters · filed 2024-11-06 | $42.29M 10-Q · filed 2024-11-06 | $58.61M derived: sum of 4 quarters · filed 2025-03-04 | ||||
| 2023-06-30 | $14.71M 10-Q · filed 2024-07-31 | $26.86M 10-Q · filed 2024-07-31 | $43.18M derived: sum of 3 quarters · filed 2025-03-04 | $56.67M derived: sum of 4 quarters · filed 2025-03-04 | ||||
| 2023-03-31 | $12.15M 10-Q · filed 2024-05-07 | $28.47M derived: sum of 2 quarters · filed 2025-03-04 | $41.96M derived: sum of 3 quarters · filed 2025-03-04 | $57.78M derived: sum of 4 quarters · filed 2025-03-04 | ||||
| 2022-12-31 | $16.32M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $29.82M derived: sum of 2 quarters · filed 2025-03-04 | $45.63M derived: sum of 3 quarters · filed 2025-03-04 | $58.84M 10-K · filed 2025-03-04 | $55.89M 10-K · filed 2023-03-08 | |||
| 2022-09-30 | $13.49M 10-Q · filed 2023-11-07 | $29.31M derived: sum of 2 quarters · filed 2023-11-07 | $42.52M 10-Q · filed 2023-11-07 | $58.35M derived: sum of 4 quarters · filed 2023-11-07 | ||||
| 2022-06-30 | $15.82M 10-Q · filed 2023-08-02 | $29.03M 10-Q · filed 2023-08-02 | $44.86M derived: sum of 3 quarters · filed 2023-08-02 | $56.35M derived: sum of 4 quarters · filed 2023-08-02 | ||||
| 2022-03-31 | $13.21M 10-Q · filed 2023-05-09 | $29.04M derived: sum of 2 quarters · filed 2023-05-09 | $40.53M derived: sum of 3 quarters · filed 2023-05-09 | $51.83M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | $15.83M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $27.32M derived: sum of 2 quarters · filed 2023-03-08 | $38.63M derived: sum of 3 quarters · filed 2023-03-08 | $43.53M 10-K · filed 2023-03-08 | ||||
| 2021-09-30 | $11.49M 10-Q · filed 2022-11-08 | $22.79M derived: sum of 2 quarters · filed 2022-11-08 | $27.70M 10-Q · filed 2022-11-08 | $34.98M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | $11.30M 10-Q · filed 2022-08-02 | $16.21M 10-Q · filed 2022-08-02 | $23.49M derived: sum of 3 quarters · filed 2022-08-02 | $28.34M derived: sum of 4 quarters · filed 2022-08-02 | ||||
| 2021-03-31 | $4.91M 10-Q · filed 2022-05-10 | $12.19M derived: sum of 2 quarters · filed 2022-05-10 | $17.04M derived: sum of 3 quarters · filed 2022-05-10 | $18.99M derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | $7.28M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $12.13M derived: sum of 2 quarters · filed 2022-03-03 | $14.08M derived: sum of 3 quarters · filed 2022-03-03 | $18.30M 10-K · filed 2022-03-03 | ||||
| 2020-09-30 | $4.85M 10-Q · filed 2021-11-02 | $6.80M derived: sum of 2 quarters · filed 2021-11-02 | $11.02M 10-Q · filed 2021-11-02 | $14.66M derived: sum of 4 quarters · filed 2021-11-02 | ||||
| 2020-06-30 | $1.95M 10-Q · filed 2021-08-04 | $6.17M 10-Q · filed 2021-08-04 | $9.80M derived: sum of 3 quarters · filed 2021-08-04 | $13.52M derived: sum of 4 quarters · filed 2021-08-04 | ||||
| 2020-03-31 | $4.22M 10-Q · filed 2021-05-12 | $7.86M derived: sum of 2 quarters · filed 2021-05-12 | $11.57M derived: sum of 3 quarters · filed 2021-05-12 | $12.23M derived: sum of 4 quarters · filed 2021-05-12 | ||||
| 2019-12-31 | $3.64M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $7.35M derived: sum of 2 quarters · filed 2021-03-25 | $8.01M derived: sum of 3 quarters · filed 2021-03-25 | $8.01M 10-K · filed 2021-03-25 | ||||
| 2019-09-30 | $3.72M 10-Q · filed 2020-10-29 | $4.38M derived: sum of 2 quarters · filed 2020-10-29 | $4.38M 10-Q · filed 2020-10-29 | $4.38M derived: sum of 4 quarters · filed 2020-10-29 | ||||
| 2019-06-30 | $660.00K 10-Q · filed 2020-08-10 | $660.00K 10-Q · filed 2020-08-10 | $660.00K derived: sum of 3 quarters · filed 2020-08-10 | $660.00K derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-11 | $0.00 derived: sum of 2 quarters · filed 2020-05-11 | $0.00 derived: sum of 3 quarters · filed 2020-05-11 | $0.00 derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $0.00 derived: sum of 2 quarters · filed 2020-02-25 | $0.00 derived: sum of 3 quarters · filed 2020-02-25 | $0.00 10-K · filed 2020-02-25 | ||||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-04 | $0.00 derived: sum of 2 quarters · filed 2019-11-04 | $0.00 10-Q · filed 2019-11-04 | |||||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-12 | $0.00 10-Q · filed 2019-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |